Bloomios Company Insiders
| BLMS Stock | USD 0.0001 0.00 0.00% |
Bloomios employs about 3 people. The company is managed by 3 executives with a total tenure of roughly 7 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Breaking down Bloomios' management performance can provide insight into the firm performance.
| John Bennett Insider Treasurer CFO |
| Barrett Evans Insider President, Officer |
Bloomios |
Bloomios Management Team Effectiveness
The company has return on total asset (ROA) of (0.7118) % which means that it has lost $0.7118 on every $100 spent on assets. This is way below average. Bloomios' management efficiency ratios could be used to measure how well Bloomios manages its routine affairs as well as how well it operates its assets and liabilities.Bloomios Workforce Comparison
Bloomios is rated second in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 1,230. Bloomios adds roughly 3.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (0.91) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.76) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.76. Bloomios Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bloomios Price Series Summation is a cross summation of Bloomios price series and its benchmark/peer.
Bloomios Notable Stakeholders
A Bloomios stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bloomios often face trade-offs trying to please all of them. Bloomios' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bloomios' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| John Bennett | Treasurer CFO | Profile | |
| Barrett Evans | President, Officer | Profile | |
| Michael Hill | CEO Chairman | Profile |
About Bloomios Management Performance
The success or failure of an entity such as Bloomios often depends on how effective the management is. Bloomios management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bloomios management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bloomios management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California. Bloomios is traded on OTC Exchange in the United States.
Please note, the imprecision that can be found in Bloomios' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bloomios. Check Bloomios' Beneish M Score to see the likelihood of Bloomios' management manipulating its earnings.
Bloomios Workforce Analysis
Traditionally, organizations such as Bloomios use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bloomios within its industry.Bloomios Manpower Efficiency
Return on Bloomios Manpower
| Revenue Per Employee | 2.8M | |
| Revenue Per Executive | 2.8M | |
| Net Loss Per Employee | 670.4K | |
| Net Loss Per Executive | 670.4K |
Additional Tools for Bloomios Pink Sheet Analysis
When running Bloomios' price analysis, check to measure Bloomios' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bloomios is operating at the current time. Most of Bloomios' value examination focuses on studying past and present price action to predict the probability of Bloomios' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bloomios' price. Additionally, you may evaluate how the addition of Bloomios to your portfolios can decrease your overall portfolio volatility.